Insights

Minaris Regenerative Medicine’s leaders and experts are proud to share their knowledge and insight with the cell and gene therapy industry. Please review our current and past blog posts on topics of interest to this emerging industry.

    *This page may include mention of our past company names as it reflects content distributed in the past. The former companies Hitachi Chemical Advanced Therapeutics Solutions (HCATS, formerly PCT or PCT Cell Therapy Services), apceth Biopharma GmBH are all now operations under the name Minaris Regenerative Medicine. Hitachi Chemical Co., Ltd. has been renamed Showa Denko Materials Co., Ltd.
    May 4, 2016

    The Future of Cell Therapy: Upcoming May Presentations Around the World

    How do you develop and manufacture a cell therapy that is deliverable? What does it take to make a cell therapy commercially viable? To do so, it must be transformative, ...

    Read More
    April 27, 2016

    Patient-Specific Cell Therapies: Not your Grandfather’s Therapies

    The following is an excerpt from an article published in the April issue of BioProcess international, entitled “Factories of the Future: Can Patient-Specific Cell ...

    Read More
    March 14, 2016

    Accelerating Our Vision of Global Commercial Cell Therapy Manufacturing

    In November 2014, Japan passed a new regenerative medicine law, the upshot of which is that it enables therapeutic development sponsors to receive conditional marketing ...

    Read More
    February 26, 2016

    Scalability in Cell-based Therapy Manufacture

    The following content, written by Thomas Heathman, MEng, PhD, Business Development Associate, PCT, was originally published on the blog of the website Technology ...

    Read More
    February 12, 2016

    The Passion for and Potential of T Cells: Expert Insights

    1. Why are T cells promising/exciting in cell therapy right now? What potential do you see? “T cells play a central role in the immune response, as they have the ...

    Read More
    December 9, 2015

    NK Cells--Why Not?

    The following post was originally published in the November 2015 edition of The Vector, the online newsletter for the American Society of Gene and Cell Therapy. Chimeric ...

    Read More
    November 10, 2015

    Cell Therapy Supply Chain Marches On

    Like an army, cell therapy marches on its stomach, and good supply chain management can (literally) keep it fed. However, the “soldiers” of cell therapy are the most ...

    Read More
    November 3, 2015

    Scoring the Goal—10 Questions to Ask your External Manufacturing Partner

    If you’re a striker (playing forward position) on a soccer team, you know that your primary role is to score a goal. But what makes you confident in your ability to ...

    Read More
    October 20, 2015

    Good Quality is Good Business—Finding your Unified Quality Voice

    The following is an excerpt from an article originally published in the October issue of BioProcess International, written by:

    Read More
    All Posts

    Subscribe to Our Email Distribution List
    © 2025 Minaris Regenerative Medicine   |  Privacy Policy   |  Imprint